Trial reportBMC anesthesiology2026
Effect of ultrasound-guided quadratus lumborum block with dexmedetomidine as an adjuvant on postoperative analgesia for gynecological laparoscopic surgery: a randomized controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeTo evaluate and compare the postoperative analgesic efficacy and safety of ultrasound-guided quadratus lumborum block using ropivacaine alone or ropivacaine supplemented with dexmedetomidine in patients undergoing elective gynecological laparoscopic surgery.
methodsWe conducted a randomized controlled trial at a tertiary hospital in China, between April 5 and December 23, 2024. Adult females undergoing gynecological laparoscopic surgery were randomly assigned to two groups. Following surgery, both groups received an ultrasound-guided posterior quadratus lumborum block; the control group (R) received ropivacaine, while the experimental group (RD) received ropivacaine combined with dexmedetomidine. Data collected included patient demographics, surgical details, consumption of rescue analgesics, Numerical Rating Scale (NRS) scores for incisional and visceral pain at rest and during movement at multiple time points, recovery outcomes, and adverse reactions.
resultsThe RD group required less rescue analgesia: total morphine consumption was 14.00 [12.00, 15.50] mg vs. 21.00 [14.00, 28.00] mg in Group R (P < 0.01); patient-controlled analgesia demands were also reduced (0.00 [0.00, 1.75] vs. 3.00 [1.00, 5.50] presses, P < 0.01); and required significantly less postoperative intravenous rescue morphine (0.0 [0.0, 0.0] mg vs. 2.5 [0.0, 5.0] mg, P < 0.01). Additionally, at most postoperative time points, the RD group had significantly lower NRS scores for incisional and visceral pain at rest and during movement (P < 0.05). No significant differences were observed in postoperative recovery or adverse events.
conclusionIn patients undergoing gynecologic laparoscopic surgery, ultrasound-guided quadratus lumborum block with ropivacaine combined with dexmedetomidine was significantly associated with a reduction in early postoperative opioid consumption, improved analgesia-related indicators, and no significant increase in adverse reactions.
trial registrationchictr.org.cn/index.aspx (ChiCTR2400082539; April 1st, 2024).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.